TNNT2 and peripheral arterial disease: The advantages of our study include a large sample size, measurement of hs-cTnT in diabetic patients across the United States, and strict measurement of traditional risk factors for lower limb disease by trained technicians using standardized protocols, including standardized monofilament testing for PN and ABI assessment for PAD.